Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2026-01-09 @ 4:04 PM
Study NCT ID:
NCT00642733
Status:
TERMINATED
Last Update Posted:
2016-08-24
First Post:
2008-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-19
First Submit QC Date:
None
Study First Post Date:
2008-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-22
Last Update Post Date:
2016-08-24
Last Update Post Date Type:
ESTIMATED